TickerGuard
Buy Day today: Neutral (59) Mixed market breadth · major macro event coming up
ONC

BeiGene, Ltd.

Healthcare · Biotechnology

356.00$ -0.8% vs. previous close Closing price · As of: Aug 13, 2026

Statements

Cash Flow

BeiGene, Ltd. (ONC) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at 664 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow ONC
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
-78 -222 -309 -96 188 75 44 264 403 417 202 664 1,686
22 24 25 25 71 50 33 36 37 210 41 82 370
96 93 89 131 115 108 95 151 141 757 123 261 1,282
-58 17 -155 -113 130 -19 -78 5.4 100 164 -190 -119 -45
182 167 193 110 134 92 116 64 48 286 41 68 443
-186 -63 -210 -111 -134 -94 -122 -67 -49 -39 -46 -95 -228
-3.6 -13 -97 26 -4.3 79 51 -17 108
-77 347 162 23 13 -4.5 -34 35 961 98 69 63 1,191
-341 105 -379 -190 95 -75 -108 255 1,324 499 244 671 2,738
-260 -389 -502 -206 55 -17 -72 200 354 131 161 596 1,243

LTM = last twelve months (sum of the four most recent quarters).

Data as of: August 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?